Explore the vast range of titles available.

背景：疲憊是頭頸癌病人於同步化放療期間最盛行的症狀，然而，穴位措施對頭頸癌病人之疲憊及心率變異效益仍未明確。目的：評值穴位措施對接受同步化放療的頭頸癌病人之疲憊及心率變異改善成效。方法：本隨機控制試驗研究採重複性測量，並以塊狀排列隨機分派病人至不同組別。穴位組與控制組的所有參與者均接受常規照護，穴位組再多接受六週體穴電刺激及耳穴貼壓。資料使用簡明疲憊量表及心率變異儀器收集，於前測、第1、2、3及6週進行測量。結果：廣義估計方程式分析的結果，呈現疲憊程度在介入措施第6週的組別與時間交互作用具有顯著差異（p＝.036），而正常心搏間期標準差、低頻功率、高頻功率及低頻／高頻功率比等心率變異參數均無組別與時間交互作用的顯著差異（p＞.05）。結論／實務應用：本研究支持穴位措施之可近性與可行性。此六週的體穴電刺激及耳穴貼壓措施，可用以改善接受化放療的頭頸癌病人的疲憊狀態，且未發現不良反應。

Fatigue is the most common symptom in head and neck cancer patients who receive concurrent chemoradiotherapy (CCRT). However, evidence of the effects of acupoint interventions on fatigue and heart rate variability in these patients is unclear. To evaluate the effect of an acupoint intervention on fatigue and heart rate variability in head and neck cancer patients receiving CCRT. This randomized controlled trail applied repeated measures, and used permuted block randomization to randomly assign the participants into the acupoint and control groups. Participants in both groups received usual care. In addition, participants in the acupoint group received transcutaneous electrical acupoint stimulation and auricular acupressure for a period of six weeks. Data were collected using the brief fatigue inventory and a heart rate variability device at baseline and during the 1st, 2nd, 3rd, and 6th weeks of the study. The generalized estimating equation analysis found a significant group-by-time interaction for fatigue o

Despite multiple interventions, the incidence of chronic pain after mastectomy could be as high as 50% after surgery. This study aimed to determine the efficacy of transcutaneous electrical acupoint stimulation (TEAS) before anesthesia induction in reducing chronic pain and to compare the effect of combined acupoint TEAS with that of single acupoint TEAS. A multicenter randomized clinical trial. The study was conducted at six medical centers in China from May 2016 to April 2018. Final follow-up was on October 26, 2018. Eligible patients were women scheduled for radical mastectomy under general anesthesia. Patients were randomly and equally grouped into sham control (n = 188), single acupoint (PC6, n = 198), or combined acupoints (PC6 and CV17, n = 190) TEAS groups using a centralized computer-generated randomization system. TEAS was applied for 30 min before anesthesia induction. The sham-operated control group received electrode attachment but without stimulation. Anesthesiologists, surgeons, and outcome assessors were blinded to the interventions. The primary endpoint was the incidence of chronic pain 6 months after surgery. Incidences were compared among the groups using the unadjusted χ2 test. Of the 576 randomized patients, 568 completed the trial. In the intention-to-treat analysis, post-mastectomy pain at 6 months was reported in 42 of 190 patients (22.1%) in the combined acupoints group, 65 of 188 patients (34.6%) in the sham-operated group (P = 0.007; relative risk [RR], 95% confidence interval [CI]: 0.68, 0.52–0.89), and 72 of 198 patients (36.4%) in the single acupoint group (P = 0.002; RR, 95% CI: 0.72, 0.55–0.93). Remifentanil consumption during surgery and postoperative nausea and vomiting at 24 h after surgery were lower in the combined acupoint group than that in the sham-operated group. TEAS at combined acupoints before surgery was associated with reduced chronic pain 6 months after surgery. Trial registration:Clinicaltrials.gov identifier: NCT02741726. Registered on April 13, 2016. •Chronic pain after radical mastectomy is not rare.•Transcutaneous electrical acupoint stimulation (TEAS) may reduce chronic pain.•TEAS at combined acupoints may be more effective.

Hypertension is often accompanied by anxiety and sleep disorders, which further complicate the disease. This study aimed to evaluate the feasibility and effectiveness of transcutaneous electrical acupoint stimulation (TEAS) in patients with hypertension and anxiety or sleep disorders. Eligible participants were randomly assigned to the 10 Hz TEAS, 2 Hz TEAS, or routine treatment groups in a 1:1:1 ratio. Participants continued their routine treatment during the trial, while those in the two TEAS groups received 12 sessions of 30-min TEAS treatment with different stimulation frequencies. The feasibility parameters were successful screening probability, enrollment rate, and dropout rate. The primary outcome was the change in office systolic blood pressure from baseline to week four. Secondary outcomes included changes in office diastolic blood pressure, heart rate, Pittsburgh Sleep Quality Index score, and Generalized Anxiety Disorder 7-item scale score from baseline to week four. Eighty-eight participants (age 58.0 [51.0, 63.0] years; 49 women) were randomized. The successful screening probability was 56.1 %, the enrollment rate was 3.1 participants per week, and the dropout rate was 14.8 %. The change in office systolic blood pressure from baseline to week four was −2.8 ± 13.6 mm Hg, −6.4 ± 10.0 mm Hg, and −7.2 ± 11.2 mm Hg, respectively, in the 10 Hz TEAS, 2 Hz TEAS, and routine treatment groups (P = 0.332). No significant differences were noted, except for a change in the Pittsburgh Sleep Quality Index score (P = 0.014). Both 10 Hz (P = 0.024) and 2 Hz TEAS (P = 0.039) significantly improved sleep quality compared to routine treatment. In patients with hypertension having anxiety or sleep disorders, this study did not demonstrate the superiority of TEAS over routine treatment but did show an improvement in sleep quality and a downward trend in diastolic blood pressure. Therefore, a largescale trial is warranted. •TEAS is feasible for patients with hypertension and anxiety/sleep disorders.•TEAS improves sleep quality of patient with hypertension and anxiety/sleep disorders.•TEAS lowers specific hypertensive patients’ DBP to Minimal Important Change extent.

Night-shift work is associated with cognitive impairments, but convenient, effective, and acceptable traditional Chinese medicine-based interventions remain limited. This study aimed to evaluate the effects of auricular acupressure combined with auricular acupoint massage on cognitive function in night-shift nurses, using P300 wave parameters from electroencephalography analysis as objective metrics. Eighty nurses (40 days-shift, 40 night-shift) participated. The intervention included auricular acupressure and massage targeting six points, performed daily for 4 weeks. Cognitive function was assessed using the Insomnia Severity Index (ISI), Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). P300 amplitude and latency were measured. Night-shift nurses had significantly higher ISI scores and lower MoCA attention, memory, and total scores compared to day-shift nurses (all < 0.05). Before the intervention, After FDR correction for multiple comparisons, P300 amplitude was significantly lower at the T4 electrode site (q = 0.020) in the night-shift group. P300 latency remained significantly prolonged at sites Fz (q = 0.020), F3 (q < 0.001), F4 (q = 0.035), and T5 (q = 0.033). Post-intervention, the night-shift group demonstrated significant increases in P300 amplitude at F3, F4, T3, T4, T5, and T6 (all q < 0.05) and significant reductions in P300 latency at Fz, F4, F7, T5, and T6 (all q < 0.05). Notably, several sites with affected P300 amplitude and latency before the intervention showed significant improvement following intervention. Auricular acupressure and massage significantly improved cognitive function in night-shift nurses, evidenced by enhanced P300 parameters. This non-invasive, cost-effective intervention shows promise for alleviating cognitive impairments from shift work.

This systematic review and meta-analysis aimed to evaluate the preventive effect of transcutaneous electrical acupoint stimulation on postoperative delirium in elderly surgical patients. PubMed, CENTRAL, China National Knowledge Infrastructure, and WanFang databases were searched for randomized controlled trials regarding the effect of transcutaneous electrical acupoint stimulation on preventing postoperative delirium in elderly patients undergoing any type of surgery. The primary outcome was the incidence of postoperative delirium. The secondary outcome was the duration of postoperative delirium. All analyses were conducted using RevMan 5.3 and Stata 13.0 software. Twelve trials with 991 participants were included, and most of them were at high/unclear risk of bias. Meta-analysis showed transcutaneous electrical acupoint stimulation could reduce the incidence of postoperative delirium (RR = 0.40, 95%CI = 0.29 to 0.55,  < 0.00001) and shorten the duration of postoperative delirium (MD = -0.97 days, 95%CI = -1.72 to -0.22,  = 0.01). Subgroup analyses demonstrated that transcutaneous electrical acupoint stimulation reduced the incidence of postoperative delirium in elderly patients undergoing orthopedic surgery and thoracic surgery, but not digestive surgery; transcutaneous electrical acupoint stimulation with dilatational wave and with continuous wave were both beneficial; and transcutaneous electrical acupoint stimulation was favored when compared to blank and sham control. Transcutaneous electrical acupoint stimulation could reduce the incidence of postoperative delirium and shorten the duration of postoperative delirium in elderly surgical patients. The findings should be interpreted with caution due to weak evidence. High-quality, large sample, and multi-center trials are needed to further confirm the preliminary findings. : https://inplasy.com/inplasy-2022-7-0096/, identifier: INPLASY202270096.

Background Irritable bowel syndrome (IBS) is a chronic functional disorder that significantly impacts patient health, causing physical discomfort and diminished quality of life. We aimed to compare various acupoint stimulation modalities for treating IBS using network meta-analysis (NMA). Methods We conducted a systematic search of five electronic databases (PubMed, Cochrane Central Register of Controlled Trials, Embase, Web of Science, and ClinicalTrials.gov) for randomized controlled trials (RCTs) on acupoint stimulation interventions for IBS published from inception to November 8, 2024, without language restrictions. Two authors independently performed data extraction and assessed the risk of bias. Outcomes included symptom severity and quality of life. Bayesian NMA was conducted using STATA 14.0 and Open BUGS 3.2.3. Results We identified 12 RCTs that included three different acupoint stimulation interventions (1839 participants)—namely, acupuncture, moxibustion, and placebo. Our NMA results showed that the three acupoint stimulation intervention therapies were effective in reducing symptom severity and improving the quality of life for patients with IBS. The most effective acupoint stimulation intervention was moxibustion, which significantly reduced symptom severity (mean difference [MD] = 101.50; 95 % credible interval [CrI]: 80.36, 122.30) and improved quality of life (MD = −19.75; 95 % CrI: −28.86, −10.75) compared to conventional medication in patients with IBS. Moreover, the adverse events of all interventions were acceptable. Conclusions The NMA suggests that moxibustion was the most effective modality in alleviating symptom severity and improving quality of life in patients with IBS, followed by acupuncture.

Background Primary insomnia is a highly prevalent sleep disorder that significantly affects quality of life. Acupoint injection (AJ), a traditional therapy that combines pharmacological and acupuncture effects, has been increasingly applied in clinical practice. However, evidence of its efficacy and economic value is lacking. This study determined the clinical effectiveness of AJ and established the relative ranks of AJ-related therapies for the treatment of primary insomnia. Methods The clinical effectiveness and cost-effectiveness of AJ-related therapies for primary insomnia were evaluated through a systematic review and network meta-analysis (NMA) of randomized controlled trials (RCTs). We searched 11 electronic databases for relevant studies published up to June 10, 2025. The Pittsburgh Sleep Quality Index (PSQI) and effective rate were used as outcome measures. The quality of included studies was assessed using the Risk of Bias 2.0 tool. Pairwise meta-analysis and NMA were performed using RevMan 5.4 and R, respectively. The cost-effectiveness of the interventions was subsequently determined based on regional intervention costs. Results Twenty-four randomized controlled trials involving 1,851 participants were included in the meta-analysis. AJ combined with manual acupuncture (MA) significantly reduced PSQI scores based on the results of the pairwise meta-analysis and was among the most effective interventions based on the results of the network meta-analysis. The cost-effectiveness analysis revealed that AJ combined with MA was associated with better outcomes at modest additional costs, as indicated by the favorable incremental cost-effectiveness ratio (ICER) values for PSQI improvement and additional responders. Conclusions This study is the first to comprehensively synthesize evidence on the clinical effectiveness and cost-effectiveness of acupoint injection for primary insomnia. AJ combined with MA significantly improves sleep quality and may be a cost-effective and safe adjunctive therapy within the context of traditional medicine practice. It may be a feasible treatment option for primary insomnia. However, this conclusion should be validated through future studies due to the limitations of the quality of the literature. Further high-quality RCTs with standardized economic evaluations are warranted to confirm these findings.

The acupuncture acupoint is the critical initial site for the therapeutic efficacy of electroacupuncture (EA). Previous studies have confirmed that the NF-κB pathway within the acupoint region mediates the therapeutic effects of acupuncture. Therefore, this study focuses on an in-depth investigation of the MD2/TLR4/NF-κB axis. The mouse model of adjuvant-induced arthritis (AIA) was established via intraplantar injection of Complete Freund's Adjuvant (CFA). EA intervention was applied bilaterally to the Zusanli (ST36) acupoints, and behavioral, molecular, and immunological approaches were integrated to investigate the role of MD2 in EA-mediated analgesia. EA increased paw thermal withdrawal thresholds (PTWTs) in AIA mice ( < 0.05), accompanied by higher levels of MD2, TLR4, p65, and the phosphorylated form of p65 (p-p65) at the acupoint. Co-immunoprecipitation (Co-IP) confirmed binding between MD2 and TLR4 in ST36 acupoint, while immunofluorescence (IF) revealed co-localization of TLR4 with fibroblasts and mast cells in ST36, suggesting these immune cells are critical targets for signal activation. Lentivirus-mediated knockdown of MD2 in the acupoint partially reversed EA's analgesic effects and suppressed downstream TLR4/NF-κB pathway activation, whereas MD2 overexpression elicited a partial analgesic effect and promoted pathway activation. Together with spinal cord proteomics data, these findings indicate that modulating MD2 in the acupoint can regulate spinal cord-related signaling pathways. Mechanistically, EA dynamically regulates the equilibrium of the Grem1/BMP4/COX2 axis in the spinal dorsal horn via activation of the MD2/TLR4/NF-κB pathway cascade, achieving systemic analgesia. This study provides molecular evidence supporting the \"acupoint priming\" theory in acupuncture and highlights MD2 as a potential therapeutic target for pain management.